CBG
Non-psychoactive hemp cannabinoid studied for anxiety, sleep, and pain relief, though human clinical evidence remains preliminary.
CBG
Non-psychoactive hemp cannabinoid studied for anxiety, sleep, and pain relief, though human clinical evidence remains preliminary.
This supplement may interact with medications, medical conditions or sensitive populations. Review safety before use.
Skip for now unless you are participating in a clinical trial — human evidence is too early to rely
Cannabigerol (CBG) is a non-intoxicating cannabinoid found in cannabis and hemp plants, not ordinary foods, usually in low amounts because it converts into other cannabinoids as the plant matures. It interacts with CB1/CB2 receptors, TRP channels, and endocannabinoid pathways that may influence pain and inflammation. Early human surveys and small studies suggest possible benefits for anxiety, sleep, and chronic pain, but robust randomized trials are still lacking.
Proven Benefits
Protocol
Onset Time
Who Should Consider
How It Works
CBG appears to modulate CB2 more than CB1 and also interacts with TRPV1, TRPA1, and alpha-2 adrenergic receptors involved in pain and autonomic signaling. It may also influence endocannabinoid tone by affecting anandamide transport or breakdown, but most evidence comes from cell and animal studies.